Melanoma Pipeline Highlights - 2018

  • ID: 4516373
  • Report
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The latest report Melanoma Pipeline Highlights - 2018, provides most up-to-date information on key pipeline products in the global Melanoma market. It covers emerging therapies for Melanoma in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Melanoma pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Melanoma pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Melanoma pipeline products by the company.

Short-term Launch Highlights:
Find out which Melanoma pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:
  • Melanoma phase 3 clinical trial pipeline products
  • Melanoma phase 2 clinical trial pipeline products
  • Melanoma phase 1 clinical trial pipeline products
  • Melanoma preclinical research pipeline products
  • Melanoma discovery stage pipeline products
  • Melanoma pipeline products short-term launch highlights
Note: Product cover images may vary from those shown
2 of 3
1. Melanoma Pipeline by Stages
2. Melanoma Pipeline by Drug Class
3. Melanoma Pipeline by Company
4. Melanoma Phase 3 Clinical Trial Insights
5. Melanoma Phase 2 Clinical Trial Insights
6. Melanoma Phase 1 Clinical Trial Insights
7. Melanoma Preclinical Research Insights
8. Melanoma Discovery Stage Insights
9. Appendix
10. Research Methodology

List of Tables
Table 1: Melanoma Phase 3 Clinical Trials, 2018
Table 2: Melanoma Phase 2 Clinical Trials, 2018
Table 3: Melanoma Phase 1 Clinical Trials, 2018
Table 4: Melanoma Preclinical Research, 2018
Table 5: Melanoma Discovery Stage, 2018

List of Figures
Figures 1: Melanoma Pipeline Molecules by Clinical Trials Stage, 2018
Figure 2: Melanoma Pipeline Molecules by Drug Class, 2018
Figure 3: Melanoma Pipeline Molecules by Company, 2018
Figure 4: Melanoma Phase 3 Clinical Trial Highlights, 2018
Figure 5: Melanoma Phase 2 Clinical Trial Highlights, 2018
Figure 6: Melanoma Phase 1 Clinical Trial Highlights, 2018
Figure 7: Melanoma Preclinical Research Highlights, 2018
Figure 8: Melanoma Discovery Stage Highlights, 2018
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll